Delving Into Borderline Personality Disorder Clinical Trial Experiences
- Conditions
- Borderline Personality Disorder
- Registration Number
- NCT05989529
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in medical study usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical research experience of borderline personality disorder patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future borderline personality disorder patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
- Aged ≥ 18 years old
- Clinical diagnosis of Borderline Personality Disorder
- Able to comprehend the investigational nature of the protocol and provide informed consent
- No diagnosis of Borderline Personality Disorder confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who remain in borderline personality disorder clinical research to trial completion 12 months Number of patients who decide to enroll in a borderline personality disorder clinical research 3 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States